Suchergebnisse - "Marcé, Sílvia"

PubPharm (41)

1

e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response

enthalten in: Journal of clinical medicine | 2024

von Marcé, S. | Méndez, A. | Xicoy, B. | +19

2

Flow cytometry to detect bone marrow involvement by follicular lymphoma

enthalten in: Cytometry Part B: Clinical Cytometry | 2022

von Aren, M. | Marce, S. | Jurado, R. | +15

3

Flow cytometry to detect bone marrow involvement by follicular lymphoma

enthalten in: Cytometry. Part B, Clinical cytometry | 2022

von Aren, M. | Marce, S. | Jurado, R. | +15

ErratumIn: Cytometry B Clin Cytom. 2023 Mar;104(2):195. - PMID 36929541

4

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients

enthalten in: HemaSphere | 2021

von Estrada, N. | Xicoy, B. | Beier, F. | +10

5

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib

enthalten in: Journal of clinical medicine | 2021

von Marcé, S. | Xicoy, B. | García, O. | +17

6

Coexistence of JAK2V617F mutation and isolated del(5q) in a patient with thrombocytosis

enthalten in: Medicina clinica | 2021

von Marcé, S. | Ruiz-Xivillé, N. | Arenillas, L.

7

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach

enthalten in: Cancers | 2021

von Acha, P. | Palomo, L. | Fuster-Tormo, F. | +10

8

FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study

enthalten in: Cytometry. Part B, Clinical cytometry | 2020

von Sorigue, M. | Junca, J. | Ferra, C. | +19

9

FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study

enthalten in: Cytometry Part B: Clinical Cytometry | 2020

von Sorigue, M. | Junca, J. | Ferra, C. | +19

10

Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms

enthalten in: American journal of hematology | 2019

von Acha, P. | Xandri, M. | Fuster-Tormo, F. | +13

1
2
3
4
5
Nächster »
[5]